API co-crystals – Trends in CMC-related aspects of pharmaceutical development beyond solubility

Kendall, 2021, An industrial perspective on co-crystals: screening identification and development of the less utilised solid form in drug discovery and development, Progress in Medicinal Chemistry, Vol. 60, 1st ed., 10.1016/bs.pmch.2021.05.001 European Medicines Agency. Reflection paper on the use of cocrystals and other solid state forms of active substances in medicinal products. EMA/CHMP/CVMP/QWP/284008/2015. May 2015. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER). Regulatory Classification of Pharmaceutical Co-Crystals Guidance for Industry. Pharmaceutical Quality/CMC, February 2018, Revision 1. Leane, 2015, A proposal for a drug product Manufacturing Classification System (MCS) for oral solid dosage forms, Pharm Dev Technol, 20, 12, 10.3109/10837450.2014.954728 Leane, 2018, Manufacturing classification system in the real world: factors influencing manufacturing process choices for filed commercial oral solid dosage formulations, case studies from industry and considerations for continuous processing, Pharm Dev Technol, 23, 964, 10.1080/10837450.2018.1534863 Nasr, 2017, Regulatory perspectives on continuous pharmaceutical manufacturing: moving from theory to practice: September 26–27, 2016, International symposium on the continuous manufacturing of pharmaceuticals, J Pharm Sci, 106, 3199, 10.1016/j.xphs.2017.06.015 Badman, 2019, Why we need continuous pharmaceutical manufacturing and how to make it happen, J Pharm Sci, 108, 3521, 10.1016/j.xphs.2019.07.016 Malamatari, 2017, Experimental cocrystal screening and solution based scale-up cocrystallization methods, Adv Drug Deliv Rev, 117, 162, 10.1016/j.addr.2017.08.006 Mishimari, 2019, Effect of two kinds of supersaturation on crystal qualities during cocrystallization, J Chem Eng Japan, 52, 579, 10.1252/jcej.18we281 Chen, 2020, Novel quasi-emulsion solvent diffusion-based spherical cocrystallization strategy for simultaneously improving the manufacturability and dissolution of indomethacin, Cryst Growth Des, 20, 6752, 10.1021/acs.cgd.0c00876 Loschen, 2018, Cocrystal ternary phase diagrams from density functional theory and solvation thermodynamics, Cryst Growth Des, 18, 5600, 10.1021/acs.cgd.8b00923 Liu, 2021, Applications of supercritical anti-solvent process in preparation of solid multicomponent systems, Pharmaceutics, 13, 13040475, 10.3390/pharmaceutics13040475 Long, 2021, Generation and physicochemical characterization of posaconazole cocrystals using Gas Antisolvent (GAS) and Supercritical Solvent (CSS) methods, J Supercrit Fluids, 170, 105134, 10.1016/j.supflu.2020.105134 Zhao, 2018, Co-crystal of paracetamol and trimethylglycine prepared by a supercritical CO2 anti-solvent process, Chem Eng Technol, 41, 1122, 10.1002/ceat.201700638 Rajadhyax, 2021, Hot melt extrusion in engineering of drug cocrystals: a review, Asian J Pharm Clin Res, 14, 10, 10.22159/ajpcr.2021.v14i8.41857 Fernandes, 2019, Mechanochemical synthesis of carvedilol cocrystals utilizing hot melt extrusion technology, J Pharm Innov, 14, 373, 10.1007/s12247-018-9360-y Srinivasan, 2021, Theophylline-nicotinamide pharmaceutical co-crystals generated using hot melt extrusion technology: impact of polymeric carriers on processability, J Drug Deliv Sci Technol, 61, 102128, 10.1016/j.jddst.2020.102128 Shaikh, 2019, Continuous, simultaneous cocrystallization and formulation of Theophylline and 4-Aminobenzoic acid pharmaceutical cocrystals using twin screw melt granulation, Eur J Pharm Sci, 137, 104981, 10.1016/j.ejps.2019.104981 Karimi-Jafari, 2022, Formation of ciprofloxacin-isonicotinic acid cocrystal using mechanochemical synthesis routes—an investigation into critical process parameters, Pharmaceutics, 14, 14030634, 10.3390/pharmaceutics14030634 Stolar, 2019, Control of pharmaceutical cocrystal polymorphism on various scales by mechanochemistry: transfer from the laboratory batch to the large-scale extrusion processing, ACS Sustain Chem Eng, 7, 7102, 10.1021/acssuschemeng.9b00043 Schenck, 2020, Recent advances in co-processed APIs and proposals for enabling commercialization of these transformative technologies, Mol Pharm, 17, 2232, 10.1021/acs.molpharmaceut.0c00198 Engku Mat Nasir, 2017, Preliminary study on operating parameters toward the metastable zone-width of carbamazepine co-crystal, Indian J Sci Technol, 10, 111216, 10.17485/ijst/2017/v10i7/111216 Chaudhari, 2021, Improved pharmaceutical properties of ritonavir through co-crystallization approach with liquid-assisted grinding method, Drug Dev Ind Pharm, 47, 1633, 10.1080/03639045.2022.2042553 Setyawan, 2020, Compression force effect on characteristics of loratadine-succinic acid cocrystal prepared by slurry method, J Res Pharm, 24, 410 Todaro, 2021, Development and characterization of ibuprofen co-crystals granules prepared via fluidized bed granulation in a one-step process–a design of experiment approach, Drug Dev Ind Pharm, 47, 292, 10.1080/03639045.2021.1879836 Todaro, 2019, In situ cocrystallization of dapsone and caffeine during fluidized bed granulation processing, AAPS PharmSciTech, 20, 1, 10.1208/s12249-018-1228-4 Tanaka, 2019, Kinetics study of cocrystal formation between indomethacin and saccharin using high-shear granulation with in situ Raman spectroscopy, J Pharm Sci, 108, 3201, 10.1016/j.xphs.2019.06.019 O’Malley, 2020, Unprecedented morphology control of gas phase cocrystal growth using multi zone heating and tailor made additives, Chem Commun, 56, 5657, 10.1039/D0CC01067G do Amaral, 2018, Development and characterization of dapsone cocrystal prepared by scalable production methods, AAPS PharmSciTech, 19, 2687, 10.1208/s12249-018-1101-5 Walsh, 2018, Production of cocrystals in an excipient matrix by spray drying, Int J Pharm, 536, 467, 10.1016/j.ijpharm.2017.12.020 Perge, 2020, Concurrent antisolvent electrospraying: a novel continuous crystallization technique, J Pharm Sci, 109, 3027, 10.1016/j.xphs.2020.06.023 Urano, 2020, Physical characteristics of cilostazol– hydroxybenzoic acid cocrystals prepared using a spray drying method, Crystals, 10, 10040313, 10.3390/cryst10040313 Engku Mat Nasir, 2020, Crystallisation parameters effect on the particle size distribution (PSD) of carbamazepine-saccharin (CBZ-SAC) co-crystals in batch cooling crystallisation, IOP Conf Ser Mater Sci Eng, 736, 022109, 10.1088/1757-899X/736/2/022109 Alatas, 2021, Fluconazole-tartaric acid co-crystal formation and its mechanical properties, Pharm Educ, 21, 116, 10.46542/pe.2021.212.116122 Kavanagh, 2021, Modulation of the powder properties of lamotrigine by crystal forms, Int J Pharm, 595, 120274, 10.1016/j.ijpharm.2021.120274 Chen, 2020, Development of piroxicam mini-tablets enabled by spherical cocrystallization, Int J Pharm, 590, 119953, 10.1016/j.ijpharm.2020.119953 Wang, 2021, Novel formulations of the antiviral drug favipiravir: improving permeability and tabletability, Cryst Growth Des, 21, 3807, 10.1021/acs.cgd.1c00150 Oh, 2021, Physicochemical characterization of dapagliflozin and its solid-state behavior in stress stability test, Drug Dev Ind Pharm, 47, 685, 10.1080/03639045.2021.1908333 Joshi, 2018, Structure-mechanics and compressibility profile study of flufenamic acid: nicotinamide cocrystal, Cryst Growth Des, 18, 5853, 10.1021/acs.cgd.8b00534 Wang, 2020, Mitigating punch sticking propensity of celecoxib by cocrystallization: an integrated computational and experimental approach, Cryst Growth Des, 20, 4217, 10.1021/acs.cgd.0c00492 Singaraju, 2020, Molecular interpretation of the compaction performance and mechanical properties of caffeine cocrystals: a polymorphic study, Mol Pharm, 17, 21, 10.1021/acs.molpharmaceut.9b00377 Latif, 2021, Improvement of physico-mechanical and pharmacokinetic attributes of naproxen by cocrystallization with L-alanine, J Drug Deliv Sci Technol, 61, 102236, 10.1016/j.jddst.2020.102236 Persson, 2018, Powder compression properties of paracetamol, paracetamol hydrochloride, and paracetamol cocrystals and coformers, J Pharm Sci, 107, 1920, 10.1016/j.xphs.2018.03.020 Emami, 2021, Solid-state interaction of pharmaceutical cocrystals with water vapor, Cryst Growth Des, 21, 4805, 10.1021/acs.cgd.1c00480 Zhang, 2021, Improving hygroscopic stability of palmatine chloride by forming a pharmaceutical salt cocrystal of palmatine chloride-gallic acid with neutral molecule, J Drug Deliv Sci Technol, 66, 102839, 10.1016/j.jddst.2021.102839 Carneiro, 2022, Mechanochemical synthesis and characterization of a novel AAs–flucytosine drug–drug cocrystal: a versatile model system for green approaches, J Mol Struct, 1251, 132052, 10.1016/j.molstruc.2021.132052 O’Sullivan, 2022, Solid-state and particle size control of pharmaceutical cocrystals using atomization-based techniques, Int J Pharm, 621, 121798, 10.1016/j.ijpharm.2022.121798 Wong, 2022, Rational development of a carrier-free dry powder inhalation formulation for respiratory viral infections via quality by design: a drug-drug cocrystal of favipiravir and theophylline, Pharmaceutics, 14, 14020300, 10.3390/pharmaceutics14020300 Salem, 2021, Synthesis and characterization of nano-sized 4-aminosalicylic acid – sulfamethazine cocrystals, Pharmaceutics, 13, 13020277, 10.3390/pharmaceutics13020277 Liu, 2021, The role of 3-OH in the self-assembly of pharmaceutical cocrystals of dihydroflavonol with 4,4′-bipyridine, New J Chem, 45, 1626, 10.1039/D0NJ04113K Yamashita, 2019, Expedited tablet formulation development of a highly soluble carbamazepine cocrystal enabled by precipitation inhibition in diffusion layer, Pharm Res, 36, 1, 10.1007/s11095-019-2622-7 Jia, 2021, Cocrystals of regorafenib with dicarboxylic acids: synthesis, characterization and property evaluation, CrystEngComm, 23, 653, 10.1039/D0CE01341B DrugBank online - a comprehensive, free-to-access, online database containing information on drugs and drug targets. https://www.go.drugbank.com/drugs. Accessed September 19 2022. Koranne, 2018, Challenges in transitioning cocrystals from bench to bedside: dissociation in prototype drug product environment, Mol Pharm, 15, 3297, 10.1021/acs.molpharmaceut.8b00340 Duggirala, 2020, Pharmaceutical cocrystals: formulation approaches to develop robust drug products, Cryst Growth Des, 20, 617, 10.1021/acs.cgd.9b00946 Aljohani, 2020, Influence of excipients on cocrystal stability and formation, Cryst Growth Des, 20, 4523, 10.1021/acs.cgd.0c00321 Yamashita, 2020, Material-sparing and expedited development of a tablet formulation of carbamazepine glutaric acid cocrystal– a QbD approach, Pharm Res, 37, 1, 10.1007/s11095-020-02855-3 US Food & Drug Administration - novel drug approvals for 2021. https://www.fda.gov/drugs/new-drugs-fda-cders-new-molecular-entities-and-new-therapeutic-biological-products/novel-drug-approvals-2021. Accessed September 19 2022.